NCT06471673
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06471673
Title A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BriaCell Therapeutics Corporation
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.